Advanced search
1 file | 1.63 MB

Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis

(2012) JOURNAL OF BIOLOGICAL CHEMISTRY. 287(18). p.14863-14872
Author
Organization
Project
Ghent researchers on unfolded proteins in inflammatory disease (GROUP-ID)
Project
Ghent researchers on unfolded proteins in inflammatory disease (GROUP-ID)
Abstract
Receptor-interacting protein kinase 1 (RIPK1) is an important component of the tumor necrosis factor receptor 1 (TNFR1) signaling pathway. Depending on the cell type and conditions, RIPK1 mediates MAPK and NF-kappa B activation as well as cell death. Using a mutant form of RIPK1 (RIPK1 Delta ID) lacking the intermediate domain (ID), we confirm the requirement of this domain for activation of these signaling events. Moreover, expression of RIPK1 Delta ID resulted in enhanced recruitment of caspase-8 to the TNFR1 complex II component Fas-associated death domain (FADD), which allowed a shift from TNF-induced necroptosis to apoptosis in L929 cells. Addition of the RIPK1 kinase inhibitor necrostatin-1 strongly reduced recruitment of RIPK1 and caspase-8 to FADD and subsequent apoptosis, indicating a role for RIPK1 kinase activity in apoptotic complex formation. Our study shows that RIPK1 has an anti-apoptotic function residing in its ID and demonstrates a cellular system as an elegant genetic model for RIPK1 kinase-dependent apoptosis that, in contrast to the Smac mimetic model, does not rely on depletion of cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2).
Keywords
NF-KAPPA-B, SIGNALING COMPLEX, MECHANISMS, TUMOR-NECROSIS-FACTOR, NONAPOPTOTIC CELL-DEATH, TNF-ALPHA, L929 CELLS, ACTIVATION, UBIQUITINATION, CIAP1

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 1.63 MB

Citation

Please use this url to cite or link to this publication:

Chicago
Duprez, Linde, Mathieu Bertrand, Tom Vanden Berghe, Yves Dondelinger, Nele Festjens, and Peter Vandenabeele. 2012. “Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch Between Necroptosis and RIPK1 Kinase-dependent Apoptosis.” Journal of Biological Chemistry 287 (18): 14863–14872.
APA
Duprez, Linde, Bertrand, M., Vanden Berghe, T., Dondelinger, Y., Festjens, N., & Vandenabeele, P. (2012). Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. JOURNAL OF BIOLOGICAL CHEMISTRY, 287(18), 14863–14872.
Vancouver
1.
Duprez L, Bertrand M, Vanden Berghe T, Dondelinger Y, Festjens N, Vandenabeele P. Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis. JOURNAL OF BIOLOGICAL CHEMISTRY. 2012;287(18):14863–72.
MLA
Duprez, Linde, Mathieu Bertrand, Tom Vanden Berghe, et al. “Intermediate Domain of Receptor-interacting Protein Kinase 1 (RIPK1) Determines Switch Between Necroptosis and RIPK1 Kinase-dependent Apoptosis.” JOURNAL OF BIOLOGICAL CHEMISTRY 287.18 (2012): 14863–14872. Print.
@article{2153307,
  abstract     = {Receptor-interacting protein kinase 1 (RIPK1) is an important component of the tumor necrosis factor receptor 1 (TNFR1) signaling pathway. Depending on the cell type and conditions, RIPK1 mediates MAPK and NF-kappa B activation as well as cell death. Using a mutant form of RIPK1 (RIPK1 Delta ID) lacking the intermediate domain (ID), we confirm the requirement of this domain for activation of these signaling events. Moreover, expression of RIPK1 Delta ID resulted in enhanced recruitment of caspase-8 to the TNFR1 complex II component Fas-associated death domain (FADD), which allowed a shift from TNF-induced necroptosis to apoptosis in L929 cells. Addition of the RIPK1 kinase inhibitor necrostatin-1 strongly reduced recruitment of RIPK1 and caspase-8 to FADD and subsequent apoptosis, indicating a role for RIPK1 kinase activity in apoptotic complex formation. Our study shows that RIPK1 has an anti-apoptotic function residing in its ID and demonstrates a cellular system as an elegant genetic model for RIPK1 kinase-dependent apoptosis that, in contrast to the Smac mimetic model, does not rely on depletion of cellular inhibitor of apoptosis protein 1 and 2 (cIAP1/2).},
  author       = {Duprez, Linde and Bertrand, Mathieu and Vanden Berghe, Tom and Dondelinger, Yves and Festjens, Nele and Vandenabeele, Peter},
  issn         = {0021-9258},
  journal      = {JOURNAL OF BIOLOGICAL CHEMISTRY},
  keyword      = {NF-KAPPA-B,SIGNALING COMPLEX,MECHANISMS,TUMOR-NECROSIS-FACTOR,NONAPOPTOTIC CELL-DEATH,TNF-ALPHA,L929 CELLS,ACTIVATION,UBIQUITINATION,CIAP1},
  language     = {eng},
  number       = {18},
  pages        = {14863--14872},
  title        = {Intermediate domain of receptor-interacting protein kinase 1 (RIPK1) determines switch between necroptosis and RIPK1 kinase-dependent apoptosis},
  url          = {http://dx.doi.org/10.1074/jbc.M111.288670},
  volume       = {287},
  year         = {2012},
}

Altmetric
View in Altmetric
Web of Science
Times cited: